Form 8-K - Current report:
SEC Accession No. 0001140361-25-027032
Filing Date
2025-07-24
Accepted
2025-07-24 07:10:15
Documents
14
Period of Report
2025-07-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20052552_8k.htm   iXBRL 8-K 32148
2 EXHIBIT 99.1 ef20052552_ex99-1.htm EX-99.1 18439
6 image00001.jpg GRAPHIC 4333
  Complete submission text file 0001140361-25-027032.txt   190695

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rckt-20250724.xsd EX-101.SCH 3877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20250724_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20250724_pre.xml EX-101.PRE 16052
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20052552_8k_htm.xml XML 4057
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 251144505
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)